医学
小梁网
青光眼
高眼压
糖皮质激素
失明
眼科
病态的
施勒姆管
疾病
生物信息学
验光服务
病理
内科学
生物
作者
Devon Hori Harvey,Chenna Kesavulu Sugali,Weiming Mao
摘要
Abstract: Glucocorticoid (GC) therapy is indicated in many diseases, including ocular diseases. An important side-effect of GC therapy is GC-induced ocular hypertension (GIOHT), which may cause irreversible blindness known as GC-induced glaucoma (GIG). Here, we reviewed the pathological changes that contribute to GIOHT including in the trabecular meshwork and Schlemm’s canal at cellular and molecular levels. We also discussed the clinical aspects of GIOHT/GIG including disease prevalence, risk factors, the type of GCs, the route of GC administration, and management strategies. Keywords: glucocorticoid, intraocular pressure, trabecular meshwork, aqueous humor outflow, mechanism, treatment
科研通智能强力驱动
Strongly Powered by AbleSci AI